Ys Biopharma Co Ltd. (YS) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ys Biopharma Co Ltd. (YS:NASDAQ), powered by AI.
- Current Price
- $0.10
- P/E Ratio
- -0.5
- Market Cap
- 67M
- Sector
- Healthcare
What is the Ys Biopharma Co Ltd. stock price forecast?
Ys Biopharma Co Ltd. is currently trading at $0.10. View real-time AI analysis on Alpha Lenz.
What is Ys Biopharma Co Ltd. insider trading activity?
View the latest insider trading data for Ys Biopharma Co Ltd. on Alpha Lenz.
What is Ys Biopharma Co Ltd.'s P/E ratio?
Ys Biopharma Co Ltd.'s P/E ratio is -0.5.
Ys Biopharma Co Ltd.
NASDAQ · YS“Ys Biopharma Co Ltd. trades at a P/E of -0.5 (undervalued) with modest ROE of -986.8%.”
Ask for details →Company Overview
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Company Statistics
FY 2023Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“Ys Biopharma Co Ltd. trades at a P/E of -0.5 (undervalued) with modest ROE of -986.8%.”
Ask for details →Frequently Asked Questions
Ys Biopharma Co Ltd. (ticker: YS) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 773 employees. Market cap is $67M.
The current price is $0.099 with a P/E ratio of -0.46x and P/B of 0.09x.
ROE is -986.83% and operating margin is -16.49%. Annual revenue is $687M.